Facetten
Zugriff
Einrichtung
Medientyp
- Text 13
Karte
Erscheinungsjahr
Autor/in
- Cavo, Michele
- Dimopoulos, Meletios A 6
- Moreau, Philippe 6
- Weisel, Katja 5
- Ludwig, Heinz 4
- alle zeigen
Sprache
- Englisch 13
13 Einträge gefunden
-
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial
- Weisel, Katja
- Dimopoulos, Meletios A
- San-Miguel, Jesús
- Paner, Agne
- Engelhardt, Monika
- Taylor, Fiona
- Lord-Bessen, Jennifer
-
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
- Mateos, Maria-Victoria
- Weisel, Katja
- De Stefano, Valerio
- Goldschmidt, Hartmut
- Delforge, Michel
- Mohty, Mohamad
- Cavo, Michele
-
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
- Dimopoulos, Meletios A
- Richardson, Paul G
- Bahlis, Nizar J
- Grosicki, Sebastian
- Cavo, Michele
- Beksaç, Meral
- Legieć, Wojciech
-
-
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
- Ludwig, Heinz
- Boccadoro, Mario
- Moreau, Philippe
- San-Miguel, Jesus
- Cavo, Michele
- Pawlyn, Charlotte
- Zweegman, Sonja
-
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
- Ludwig, Heinz
- Sonneveld, Pieter
- Facon, Thierry
- San-Miguel, Jesus
- Avet-Loiseau, Hervé
- Mohty, Mohamad
- Mateos, Maria-Victoria
-
-
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
- Chari, Ajai
- Munder, Markus
- Weisel, Katja
- Jenner, Matthew
- Bygrave, Ceri
- Petrucci, Maria Teresa
- Boccadoro, Mario
-
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
- Mateos, Maria-Victoria
- Spencer, Andrew
- Nooka, Ajay K
- Pour, Ludek
- Weisel, Katja
- Cavo, Michele
- Laubach, Jacob P
-
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
- Goldschmidt, Hartmut
- Dimopoulos, Meletios A
- Rajkumar, S Vincent
- Weisel, Katja C
- Moreau, Philippe
- Chng, Wee-Joo
- Mikala, Gábor
-
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis
- Dimopoulos, Meletios A
- Niesvizky, Ruben
- Weisel, Katja
- Siegel, David S
- Hajek, Roman
- Mateos, María-Victoria
- Cavo, Michele
-
-
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
- Cavo, Michele
- Rajkumar, S Vincent
- Palumbo, Antonio
- Moreau, Philippe
- Orlowski, Robert
- Bladé, Joan
- Sezer, Orhan